| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07506057 | Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of… | Urothelial Carcinoma | Recruiting |
| Not specified | |||
| NCT07492238 | Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in… | Colorectal Cancer | Active, Not Recruiting |